Enhancement of anti-tumor efficacy of immune checkpoint blockade by alpha-TEA

Cancer immunotherapy such as anti-PD-1/anti-PD-L1 immune checkpoint blockade (ICB) can provide significant clinical benefit in patients with advanced malignancies. However, most patients eventually develop progressive disease, thus necessitating additional therapeutic options. We have developed a no...

Descripción completa

Detalles Bibliográficos
Autores principales: Redmond, William L., Kasiewicz, Melissa J., Akporiaye, Emmanuel T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992800/
https://www.ncbi.nlm.nih.gov/pubmed/36911733
http://dx.doi.org/10.3389/fimmu.2023.1057702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992800/
https://www.ncbi.nlm.nih.gov/pubmed/36911733
http://dx.doi.org/10.3389/fimmu.2023.1057702

Ejemplares similares